Inari Medical (NASDAQ:NARI) Price Target Raised to $80.00
Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...
Inari Medical (NASDAQ:NARI) Cut to “Hold” at Baird R W
Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research ...
Balanced Outlook on ResMed: Strong Execution and Innovations Offset by Valuation Concerns and Market Challenges
Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...
Ag Funder News20h
The Week in AgriFoodTech: India’s Botanic Healthcare bags $29m, Fermata secures $10m, Plenty facing value cut
Agriculture-focused data science company Fermata secured $10 million while vertical farming company Plenty faces a value cut.
North American Morning Briefing: Investors On -2-
National American University Holdings Inc (NAUH) is expected to report for 2Q. Neogen Corp (NEOG) is expected to report $-0.01 for 2Q. NexImmune Inc (NEXI) is expected to report for 3Q.
medtechdive23h
5 medtech trends to watch in 2025
After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...